United StatesÚltimas notícias

Invivyd (NASDAQ:IVVD) has initiated dosing in its LIBERTY Phase 3 clinical trial, a randomized, double-blind study designed to evaluate the safety, tolerability, and immunology of its investigational monoclonal antibody candidate, VYD2311, alone and co-administered with an mRNA COVID-19 vaccine in healthy adults.

Alterity Therapeutics (NASDAQ:ATHE) has successfully concluded an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA), securing critical regulatory alignment on the design of its upcoming pivotal Phase 3 clinical program for lead candidate ATH434.

Lands' End (NASDAQ:LE) reported a substantial swing to first-quarter net profitability due to a major brand management transaction, shielding the company's bottom line from a drop in core e-commerce and retail revenue.

SailPoint (NASDAQ:SAIL) reported a 22% increase in first-quarter revenue, driven by robust enterprise adoption of its software-as-a-service identity management platforms amid tightening regulatory mandates for corporate data security.

CECO Environmental (NASDAQ:CECO) raised its full-year 2026 financial guidance, factoring in the initial operational contributions from its recently finalized acquisition of Thermon Group Holdings.

United Natural Foods (NYSE:UNFI) reported a return to profitability for the third quarter of fiscal year 2026, as targeted overhead reductions and warehouse optimization measures successfully offset a moderate contraction in top-line sales.

The J.M. Smucker Company (NYSE:SJM) reported a 20% increase in fourth-quarter adjusted earnings per share, driven by favorable pricing actions and portfolio management, while issuing a forward-looking forecast that projects a modest revenue contraction for the upcoming fiscal year.

Titan Machinery (NASDAQ:TITN) reported a double-digit decline in first-quarter revenue, swinging to a net loss as a broader cyclical slowdown in global agricultural and construction markets continues to weigh on heavy equipment retail volumes.

Burning Rock Biotech (NASDAQ:BNR) reported an 18.9% drop in first-quarter revenue for fiscal year 2026, as lower volumes across its core diagnostic testing and pharmaceutical services lines countered ongoing cost-containment measures.

Designer Brands (NYSE:DBI) reported a slight expansion in its first-quarter top-line revenue, driven by strong growth within its wholesale division that helped offset softening demand across its core brick-and-mortar storefront network.

Parsons (NYSE:PSN) has secured an additional $73 million contract from the Air Force Research Laboratory to continue supporting its Global Application Research, Development, Engineering and Maintenance (GARDEM) mission.

Jack Caffrey, equity portfolio manager at JPMorgan Asset Management, examines the impact of oil prices on equity markets and what that means for both short-term traders and long-term investors.